Bronchospasm secondary to nebulised antibiotics in bronchiectasis

R. Njafuh (SOUTHSEA, United Kingdom)

Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Njafuh (SOUTHSEA, United Kingdom). Bronchospasm secondary to nebulised antibiotics in bronchiectasis. 4069

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Inhaled antibiotics in non-cystic fibrosis bronchiectasis: better than oral antibiotics?
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016

Distribution of nebulised gentamicin in patients with bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 640s
Year: 2004

Antibiotic treatment strategies in adults with bronchiectasis
Source: Eur Respir Mon 2011; 52: 211-222
Year: 2011

Exacerbations and inhaled corticosteroids in bronchiectasis patients
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019

Inhaled colistin in elderly patients with bronchiectasis and chronic bronchial infection with pseudomonas
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012

Nebulized saline treatment in patients with concomitant asthma and bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021

Nebulized therapy in bronchial asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 52s
Year: 2002

Effectiveness of inhaled colistin by iNeb® device in non-CF bronchiectasis and chronic pseudomonas infection
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015

Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis
Source: Eur Respir J, 54 (1) 1801896; 10.1183/13993003.01896-2018
Year: 2019

Τhe administration of nebulised racemic epinephrine in asthma exacerbations
Source: Eur Respir J 2004; 24: Suppl. 48, 541s
Year: 2004

Inhaled antibiotics in chronic airway infections
Source: Eur Respir Monogr 2017; 75: 57-79
Year: 2017

Comparison of treatments with nebulised salbutamol and epinephrine in acute bronchiolitis
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Year: 2004

Oral antibiotics vs placebo for exacerbations of paediatric bronchiectasis
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection
Year: 2019

Efficacy of nebulised adrenaline and salbutamol on mild to moderate bronchiolitis
Source: Annual Congress 2003 - New perspectives in bronchiolitis
Year: 2003

Inhaled antimicrobials
Source: ERS webinar 2020: Inhaled antimicrobials
Year: 2020

The clinical impact of nebulised antibiotics in adults with bronchiectasis and chronic pseudomonas aeruginosa
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020

Prescription of Inhaled corticosteroid in non-cystic fibrosis bronchiectasis:a solution or a problem
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020

Co-dispensing of inhaled corticosteroids and antibiotics
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Year: 2012

Inhaled steroids in children with non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 392s
Year: 2004

The low dose macrolides for prevention of exacerbations in non-CF bronchiectasis
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015